Mark and Mary Stevens Neuroimaging and Informatics Institute of the University of Southern California
Los Angeles, California, 90033, United States
NCT Number: NCT04678778
The overarching goal of this pilot clinical trial is to use a novel virtual reality (VR)-based intervention that simultaneously engages physical and cognitive activity aimed at improving brain and cognitive outcomes in older adults. Physical activity is a promising lifestyle intervention for mitigating cognitive decline or delaying onset of dementia. However, to fully leverage beneficial brain effects of physical activity, training the brain to learn and engage in a cognitively stimulating environment may be the key to enhanced brain and cognitive outcomes.
Looking for future studies?
Notify Me50 year–85 year
All sexes
Interventional
Not applicable
Los Angeles, California, 90033, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
There are three sessions a week for the course of 12 weeks. Each session consists of 5 trials.
Time frame: 12 weeks
The hippocampus has been shown to be a selectively vulnerable region in Alzheimer's Disease (AD), and several studies, including our own, identified a dysfunctional brain signal in the hippocampus in Mild Cognitive Impairment (MCI) patients. We propose to examine the effects of exercise on remediating this hyperactive signal exhibited in MCI patients.
Time frame: 12 weeks
With the study's primary focus on hippocampal function, we will use the Mnemonic Separation Task (MST), a hippocampus-dependent discrimination test of similar objects, as our primary cognitive outcome.
University of Southern California
Other
Targeted Physical and Cognitive Activity in a VR Environment - COVID-19 Protocol
Acronym: NRVR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05559203
Aged, Aging
Perth, United Kingdom
View Trial DetailsNCT06584656
Alzheimer Disease, Behavior
Granada, Andalusia, Spain
View Trial DetailsNCT05031273
Behavior, Healthy Aging
Edmonton, Alberta, Canada
View Trial DetailsNCT05462977
Affect, Alzheimer Disease
Greensboro, North Carolina, United States
View Trial Details